BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
98 results:

  • 1. Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms.
    Collins TB; Laranjeira ABA; Kong T; Fulbright MC; Fisher DAC; Sturgeon CM; Batista LFZ; Oh ST
    Exp Hematol; 2024 Apr; 132():104178. PubMed ID: 38340948
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Transferrin receptor in primary and metastatic breast cancer: Evaluation of expression and experimental modulation to improve molecular targeting.
    Fontana F; Esser AK; Egbulefu C; Karmakar P; Su X; Allen JS; Xu Y; Davis JL; Gabay A; Xiang J; Kwakwa KA; Manion B; Bakewell S; Li S; Park H; Lanza GM; Achilefu S; Weilbaecher KN
    PLoS One; 2023; 18(12):e0293700. PubMed ID: 38117806
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Investigation of the activity of a novel tropolone in osteosarcoma.
    Haney SL; Feng D; Kollala SS; Chhonker YS; Varney ML; Williams JT; Ford JB; Murry DJ; Holstein SA
    Drug Dev Res; 2024 Feb; 85(1):e22129. PubMed ID: 37961833
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. 3-AP inhibits the growth of human osteosarcoma by decreasing the activity of the iron-dependent pathway.
    Huang S; Zhang D; Yi X; Liu C; Jian C; Yu A
    Med Oncol; 2023 Nov; 40(12):353. PubMed ID: 37952032
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
    Bauer K; Machherndl-Spandl S; Kazianka L; Sadovnik I; Gültekin S; Suessner S; Proell J; Lauf J; Hoermann G; Eisenwort G; Häfner N; Födermayr-Mayrleitner M; Schmolke AS; van der Kouwe E; Platzbecker U; Lion T; Weltermann A; Zach O; Webersinke G; Germing U; Gabriel C; Sperr WR; Béné MC; Staber PB; Bettelheim P; Valent P
    Leukemia; 2023 Nov; 37(11):2250-2260. PubMed ID: 37673973
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunotherapy with CD25/cd71-allodepleted T cells to improve T-cell reconstitution after matched unrelated donor hematopoietic stem cell transplant: a randomized trial.
    Peggs KS; Albon SJ; Oporto Espuelas M; Irving C; Richardson R; Casanovas-Company J; Wallace R; Guvenel A; Ghorashian S; Collura A; Subramaniyam M; Flutter B; Popova B; Castro F; Lopes A; Champion K; Schofield O; Clifton-Hadley L; Taylor T; Farrell M; Adams S; Gilmour KC; Mackinnon S; Tholouli E; Amrolia PJ
    Cytotherapy; 2023 Jan; 25(1):82-93. PubMed ID: 36220712
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Flow cytometry immunophenotypic features of pure erythroid leukemia and the distinction from reactive erythroid precursors.
    Fang H; Wang SA; You MJ; Hu S; Miranda RN; Tang Z; Lin P; Jorgensen JL; Xu J; Thakral B; Schlette EJ; El Hussein S; Bueso-Ramos C; Medeiros LJ; Wang W
    Cytometry B Clin Cytom; 2022 Nov; 102(6):440-447. PubMed ID: 36156384
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Unique molecular and functional features of extramedullary hematopoietic stem and progenitor cell reservoirs in humans.
    Mende N; Bastos HP; Santoro A; Mahbubani KT; Ciaurro V; Calderbank EF; Quiroga Londoño M; Sham K; Mantica G; Morishima T; Mitchell E; Lidonnici MR; Meier-Abt F; Hayler D; Jardine L; Curd A; Haniffa M; Ferrari G; Takizawa H; Wilson NK; Göttgens B; Saeb-Parsy K; Frontini M; Laurenti E
    Blood; 2022 Jun; 139(23):3387-3401. PubMed ID: 35073399
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Potent but transient immunosuppression of T-cells is a general feature of cd71
    Grzywa TM; Sosnowska A; Rydzynska Z; Lazniewski M; Plewczynski D; Klicka K; Malecka-Gieldowska M; Rodziewicz-Lurzynska A; Ciepiela O; Justyniarska M; Pomper P; Grzybowski MM; Blaszczyk R; Wegrzynowicz M; Tomaszewska A; Basak G; Golab J; Nowis D
    Commun Biol; 2021 Dec; 4(1):1384. PubMed ID: 34893694
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.
    Julián-Serrano S; Yuan F; Wheeler W; Benyamin B; Machiela MJ; Arslan AA; Beane-Freeman LE; Bracci PM; Duell EJ; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Marchand LL; Neale RE; Shu XO; Van Den Eeden SK; Visvanathan K; Zheng W; Albanes D; Andreotti G; Ardanaz E; Babic A; Berndt SI; Brais LK; Brennan P; Bueno-de-Mesquita B; Buring JE; Chanock SJ; Childs EJ; Chung CC; Fabiánová E; Foretová L; Fuchs CS; Gaziano JM; Gentiluomo M; Giovannucci EL; Goggins MG; Hackert T; Hartge P; Hassan MM; Holcátová I; Holly EA; Hung RI; Janout V; Kurtz RC; Lee IM; Malats N; McKean D; Milne RL; Newton CC; Oberg AL; Perdomo S; Peters U; Porta M; Rothman N; Schulze MB; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Weiderpass E; Wenstzensen N; White E; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Zhong J; Kraft P; Li D; Campbell PT; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Klein AP; Yu K; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2021 Oct; 114(4):1408-1417. PubMed ID: 34258619
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The role of cd71
    Grzywa TM; Nowis D; Golab J
    Pharmacol Ther; 2021 Dec; 228():107927. PubMed ID: 34171326
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. On Iron Metabolism and Its Regulation.
    Vogt AS; Arsiwala T; Mohsen M; Vogel M; Manolova V; Bachmann MF
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925597
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Preferential uptake of antibody targeted calcium phosphosilicate nanoparticles by metastatic triple negative breast cancer cells in co-cultures of human metastatic breast cancer cells plus bone osteoblasts.
    Bussard KM; Gigliotti CM; Adair BM; Snyder JM; Gigliotti NT; Loc WS; Wilczynski ZR; Liu ZK; Meisel K; Zemanek C; Mastro AM; Shupp AB; McGovern C; Matters GL; Adair JH
    Nanomedicine; 2021 Jun; 34():102383. PubMed ID: 33722692
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects.
    Seu KG; Trump LR; Emberesh S; Lorsbach RB; Johnson C; Meznarich J; Underhill HR; Chou ST; Sakthivel H; Nassar NN; Seu KJ; Blanc L; Zhang W; Lutzko CM; Kalfa TA
    Am J Hum Genet; 2020 Dec; 107(6):1149-1156. PubMed ID: 33186543
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Hematopoietic Stem Cell Transplantation Is a Curative Therapy for Transferrin Receptor 1 (tfrc) Deficiency.
    Whangbo JS; Chou J; Al-Dhekri H; Harris M; Geha RS; Pai SY; Al-Herz W
    J Allergy Clin Immunol Pract; 2021 Feb; 9(2):753-759.e2. PubMed ID: 33096268
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Successful Treatment of a Patient with Chronic Myelogenous Leukemia with Concurrent Janus Kinase 2 (JAK2) R795S Mutation and Breakpoint Cluster Region-ABL1 (BCR-ABL1) Fusion: A Case Report and Literature Review.
    Yue Y; Wei W; Guo Y; Wang F; Dong W; Liu Y; Lin Y; Cao Y; Gu W
    Am J Case Rep; 2020 Oct; 21():e925151. PubMed ID: 33021971
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Coexpression of cd71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human bone Marrow.
    Dinh HQ; Eggert T; Meyer MA; Zhu YP; Olingy CE; Llewellyn R; Wu R; Hedrick CC
    Immunity; 2020 Aug; 53(2):319-334.e6. PubMed ID: 32814027
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Enasidenib drives human erythroid differentiation independently of isocitrate dehydrogenase 2.
    Dutta R; Zhang TY; Köhnke T; Thomas D; Linde M; Gars E; Stafford M; Kaur S; Nakauchi Y; Yin R; Azizi A; Narla A; Majeti R
    J Clin Invest; 2020 Apr; 130(4):1843-1849. PubMed ID: 31895700
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An IgG1 Version of the Anti-transferrin Receptor 1 Antibody ch128.1 Shows Significant Antitumor Activity Against Different Xenograft Models of Multiple Myeloma: A Brief Communication.
    Daniels-Wells TR; Candelaria PV; Leoh LS; Nava M; Martínez-Maza O; Penichet ML
    J Immunother; 2020; 43(2):48-52. PubMed ID: 31693515
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
    Wu H; Zhang J; Dai R; Xu J; Feng H
    J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.